Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Carcinoma (RCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01408004
What this trial is testing

Rotating Pazopanib and Everolimus to Avoid Resistance

Who this might be right for
Clear Cell Renal Carcinoma
Netherlands Working Group on Immunotherapy of Oncology 101
Testing effectiveness (Phase 2)Temporarily pausedNCT05928806
What this trial is testing

Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial

Who this might be right for
Advanced Renal Cell Carcinoma
Michael B. Atkins, MD 120
Post-approval studies (Phase 4)Study completedNCT01206764
What this trial is testing

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

Who this might be right for
Renal Cell Carcinoma
Novartis Pharmaceuticals 143
Early research (Phase 1)Study completedNCT02835833
What this trial is testing

Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors

Who this might be right for
Renal Cell CarcinomaColorectal AdenocarcinomaNon-squamous Non-small Cell Lung Cancer+2 more
University of Alabama at Birmingham 21
Testing effectiveness (Phase 2)Ended earlyNCT02089334
What this trial is testing

Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Renal Cell Cancer
Rexahn Pharmaceuticals, Inc. 24
Early research (Phase 1)Temporarily pausedNCT05967533
What this trial is testing

The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors

Who this might be right for
Advanced Colorectal CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+13 more
University of California, Davis 100
Testing effectiveness (Phase 2)Study completedNCT00333502
What this trial is testing

Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors

Who this might be right for
CancerSolid Tumor
NewLink Genetics Corporation 62
Early research (Phase 1)Ended earlyNCT04551885
What this trial is testing

FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 12
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT04300140
What this trial is testing

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Aravive, Inc. 72
Early research (Phase 1)Ended earlyNCT02837991
What this trial is testing

A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)Clear-cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+3 more
Celldex Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT00325507
What this trial is testing

Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Oxford BioMedica 25
Testing effectiveness (Phase 2)UnknownNCT06222125
What this trial is testing

HB0025 Injection in Patients With Advanced Renal Cancer

Who this might be right for
Renal Cancer
Huabo Biopharm Co., Ltd. 100
Testing effectiveness (Phase 2)Ended earlyNCT00831480
What this trial is testing

Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal

Who this might be right for
Kidney Cancer
Linda C. Higgins 15
Not applicableStudy completedNCT02187042
What this trial is testing

Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line

Who this might be right for
Metastatic/Advanced Renal Cell Carcinoma
Pfizer 70
Early research (Phase 1)Study completedNCT06108479
What this trial is testing

Study of DF6215 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultSolid Tumor Cancer
Dragonfly Therapeutics 35
Testing effectiveness (Phase 2)UnknownNCT03961698
What this trial is testing

Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma

Who this might be right for
Breast CancerRenal Cell Carcinoma
Infinity Pharmaceuticals, Inc. 91
Testing effectiveness (Phase 2)Study completedNCT01524926
What this trial is testing

CREATE: Cross-tumoral Phase 2 With Crizotinib

Who this might be right for
Locally Advanced and/or Metastatic Anaplastic Large Cell LymphomaLocally Advanced and/or Metastatic Inflammatory Myofibroblastic TumorLocally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1+3 more
European Organisation for Research and Treatment of Cancer - EORTC 582
Early research (Phase 1)Study completedNCT02454478
What this trial is testing

Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)

Who this might be right for
Carcinoma, Renal Cell
Eisai Co., Ltd. 7
Not applicableLooking for participantsNCT04712305
What this trial is testing

Urine Omics Predicting IO Therapy Responses in mRCC Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
National Taiwan University Hospital 400
Next Page